Epitope seeks bigger HIV diagnostics share in US:
This article was originally published in Clinica
Epitope, a US maker of oral fluid diagnostics tests, has been attempting to broaden its domestic sales base by extending its marketing of its principal product, OraSure, into the military, community AIDS outreach and physician community. OraSure, which competes with blood and urine-based tests for HIV, is being developed by Beaverton, Oregon-based Epitope and its research partner, STC Technologies, for applications in drugs-of-abuse testing as well as hepatitis and syphilis.
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.